Log In
BCIQ
Print this Print this
 

Thymira

  Manage Alerts
Collapse Summary General Information
Company Prolias Technologies Inc.
DescriptionDiagnostic test comprised of 4 biomarkers that measure microRNA expression levels from a sample using Fine Needle Aspiration (FNA)
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnostic test used to differentiate between benign and malignant indeterminate thyroid FNA lesions
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/19/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today